Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 400 of 741 entries
View as:
Study of Genotype and Phenotype Characterization in Duchenne Muscular Dystrophy With Small Mutations
Phase: N/A
Priority: Normal
Start: 03/18/22
End: 06/30/24
Due: 06/30/25
Phase: N/A
Priority: Normal
Start: 01/09/20
End: 12/30/20
Due: 12/30/21
Phase: N/A
Priority: Normal
Start: 03/01/22
End: 11/30/24
Due: 11/30/25
Phase: N/A
Priority: Normal
Start: 07/01/22
End: 06/30/27
Due: 06/30/28
Phase: N/A
Priority: Normal
Start: 07/01/21
End: 07/31/25
Due: 07/31/26
Phase: N/A
Priority: Normal
Start: 12/01/24
End: 12/01/28
Due: 12/01/29
Phase: N/A
Priority: Normal
Start: 04/03/25
End: 01/15/27
Due: 01/15/28
Phase: N/A
Priority: Normal
Start: 06/01/20
End: 05/01/24
Due: 05/01/25
Phase: N/A
Priority: Normal
Start: 05/31/25
End: 03/31/26
Due: 03/31/27
Phase: N/A
Priority: Normal
Start: 01/10/25
End: 01/10/31
Due: 01/10/32
Phase: N/A
Priority: Normal
Start: 01/12/24
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 12/20/24
End: 04/30/28
Due: 04/30/29
Phase: N/A
Priority: Normal
Start: 05/01/19
End: 02/29/20
Due: 02/28/21
Phase: N/A
Priority: Normal
Start: 01/01/97
End: 08/31/23
Due: 08/31/24
Phase: N/A
Priority: Normal
Start: 02/27/20
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 07/03/21
End: 09/24/24
Due: 09/24/25
Phase: N/A
Priority: Normal
Start: 03/13/25
End: 03/10/27
Due: 03/10/28
Phase: N/A
Priority: Normal
Start: 10/31/23
End: 10/06/25
Due: 10/06/26
Phase: N/A
Priority: Normal
Start: 04/22/21
End: 04/22/26
Due: 04/22/27
Phase: N/A
Priority: Normal
Start: 11/07/22
End: 04/30/25
Due: 04/30/26
Phase: N/A
Priority: Normal
Start: 06/01/22
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 06/23/22
End: 07/30/24
Due: 07/30/25
Phase: N/A
Priority: Normal
Start: 01/15/24
End: 07/31/26
Due: 07/31/27
Phase: N/A
Priority: Normal
Start: 03/20/23
End: 05/02/26
Due: 05/02/27
Phase: N/A
Priority: Normal
Start: 09/30/24
End: 12/30/32
Due: 12/30/33